7 Key Things You Need to Know About Tariffs and Pharmaceuticals
There’s been renewed attention on tariffs following the April 2, 2025 executive order introducing reciprocal trade measures. While pharmaceuticals are […]
Stay Informed, Stay Ahead: CVS’s Transition from Humira to Biosimilars
Earlier this month, CVS announced a major change to some of their formularies. This includes the removal of Humira, a widely used medication.
Levemir Discontinuation: What You Need to Know
Important update regarding a recent development about Novo Nordisk’s announcement to discontinue Levemir.
Medicaid AMP Cap Removal: Market Changes & Rx Strategies Amidst New Provisions
This article dives deep into these shifts and the subsequent reactions from industry stakeholders.
The Cost Implications of New Weight Loss Treatments for Plan Sponsors
Obesity complications are a huge driver of healthcare costs. Could drugs in the latest generation of medications approved to promote weight loss be a solution? These drugs have high costs as well, so payers looking to find the balance don’t face an easy decision of whether or not to cover them.
